Loading...
NSC23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein (Pgp) and enhancing apoptosis
Strategies to prevent the emergence of drug resistance will increase the effectiveness of chemotherapy treatment and prolong survival of women with ovarian cancer. The aim of the current study is to determine the effects of NSC23925 on preventing the development of paclitaxel resistance in ovarian c...
Saved in:
| Published in: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529776/ https://ncbi.nlm.nih.gov/pubmed/25904021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.29574 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|